|
|
Volumn 331, Issue 6024, 2011, Pages 1542-1545
|
|
Combining targeted drugs to stop resistant tumors
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
B RAF KINASE;
BCR ABL PROTEIN;
DASATINIB;
EPIDERMAL GROWTH FACTOR RECEPTOR;
ERLOTINIB;
GEFITINIB;
IMATINIB;
NILOTINIB;
PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR;
PLX 4032;
SUNITINIB;
CANCER RESISTANCE;
CANCER THERAPY;
CHRONIC MYELOID LEUKEMIA;
DRUG TARGETING;
GASTROINTESTINAL STROMAL TUMOR;
HUMAN;
LUNG NON SMALL CELL CANCER;
MELANOMA;
NEOPLASM;
NOTE;
PHILADELPHIA 1 CHROMOSOME;
PRIORITY JOURNAL;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
DRUG RESISTANCE, NEOPLASM;
HUMANS;
MOLECULAR TARGETED THERAPY;
NEOPLASMS;
|
|
EID: 79953141616
PISSN: 00368075
EISSN: 10959203
Source Type: Journal
DOI: 10.1126/science.331.6024.1542 Document Type: Note |
|
Times cited : (46)
|
|
References (0)
|
